Ranking
Best Tirzepatide Providers
This ranking orders tirzepatide providers by a computed effective monthly cost, and only includes records where mandatory-fee inclusion is confirmed so the comparison is like-for-like. Providers whose advertised price cannot be normalised are excluded and listed with reasons. No editorial score is applied, and one provider, NexLife, is a disclosed commercial partner of this publication (affiliate/referral, since 2026-09-04) — labeled where it appears and not an input to the ordering.
Key takeaways
- Ranking uses computed cost only — there is no subjective editorial score to hide preference in.
- Only providers with confirmed fee inclusion are ranked; the rest are excluded with published reasons.
- Advertised 'from' prices that exclude fees appear in a separate, clearly-labelled table.
- Cost alone does not identify the best provider — pharmacy and clinician verification remain incomplete.
- No provider can buy inclusion, position, or wording; the one commercial relationship (NexLife, affiliate/referral since 2026-09-04) is disclosed, labelled, and not a ranking input.
| Criterion | Overall, by verified cost transparency |
|---|---|
| Records reviewed | 29 |
| Eligible | 7 |
| Excluded | 22 |
| Ordering | Computed cost only — no editorial score |
| Methodology | v1.0 |
| Publisher relationship with providers | NexLife — disclosed commercial partner (affiliate/referral, since 2026-09-04), labeled where it appears; not an input to the ordering. No other provider has any relationship |
Which providers rank highest?
| # | Provider | Effective $/mo | Basis | Mandatory fees | Price verified |
|---|---|---|---|---|---|
| 1 | TRYM Health | $125 | complete published commitment ladder for the standard injection: medication included, no separate membership or shipping fee | No hidden membership/shipping fees advertised | 2026-07-20 |
| 2 | Trimi | $125 | complete published commitment ladder for the standard injection: medication included, no separate membership or shipping fee | No membership fee (stated); visit, prescription, clinician support and | 2026-09-04 |
| 3 | NexLife | $139 | complete published commitment ladder for the standard injection: medication included, no separate membership or shipping fee | No separate membership fee; consultations and expedited shipping adver | 2026-09-04 |
| 4 | Yucca Health | $225 | complete published commitment ladder (monthly, 3- and 6-month; no 12-month tier) for the standard injection: medication included, no separate membership fee | None reported; consultation, injection kit and 2-day shipping stated a | 2026-09-04 |
| 5 | Fridays | $240 | advertised monthly rate with medication included and no separate membership fee | Generally advertised as all-inclusive | 2026-07-20 |
| 6 | Mochi Health | $278 | effective recurring cost: medication plus every mandatory fee, computed from the captured components | Membership $39 first month, then $79/month; shipping advertised includ | 2026-07-20 |
| 7 | Eden | $298 | effective recurring cost: medication plus every mandatory fee, computed from the captured components | Membership separate | 2026-07-20 |
Why does this ranking refuse to name an overall winner?
Because "best" would require weighting cost against pharmacy verification, clinician access, dose coverage, and cancellation terms — and four of those five are unverified across the entire dataset. Any overall score would therefore be mostly cost with a decorative wrapper, presented as though it measured something broader.
Ordering by computed cost and saying so is less impressive and more accurate. When the pharmacy and policy fields are verified, categories that depend on them will be ranked on their own terms rather than folded into a composite.
What separates a like-for-like price from an advertised one?
A like-for-like figure is the amount that leaves your account every month once every mandatory charge is included. An advertised figure is whatever the provider chose to put on the pricing page, which frequently covers medication only. Two providers can advertise $99 and $139 and cost $178 and $139 respectively.
This ranking only orders records where that distinction has been resolved from public information. The rest appear in the exclusion table with the reason.
What was the sample, and what was excluded?
Sample: 29 provider records reviewed, 7 eligible for this category, 22 excluded. Methodology v1.0; each record carries its own price-verification date.
| Provider | Reason for exclusion |
|---|---|
| OrderlyMeds | Advertised as a “from” starting price, not a recurring all-in cost |
| Henry Meds | Price stated in free text that cannot be normalised |
| Ivím Health | Price stated in free text that cannot be normalised |
| Amble | Price stated in free text that cannot be normalised |
| Lavender Sky Health | Advertised as a “from” starting price, not a recurring all-in cost |
| Fifty 410 | Advertised as a “from” starting price, not a recurring all-in cost |
| ShedRx / SHED | Advertised as a “from” starting price, not a recurring all-in cost |
| Remedy Meds | Mandatory-fee inclusion not confirmed in the captured source |
| Willow | Advertised as a “from” starting price, not a recurring all-in cost |
| GobyMeds | Price stated in free text that cannot be normalised |
| Zappy Health | Price stated in free text that cannot be normalised |
| SlimDownRx | Price stated in free text that cannot be normalised |
| Valhalla Vitality | Price stated in free text that cannot be normalised |
| Hims & Hers | Advertised figure covers medication only; mandatory care or membership fees billed separately |
| Ro Body | Price stated in free text that cannot be normalised |
| WeightWatchers Clinic | Advertised figure covers medication only; mandatory care or membership fees billed separately |
| Noom Med | Price stated in free text that cannot be normalised |
| LifeMD | Advertised as a “from” starting price, not a recurring all-in cost |
| Found | Advertised as a “from” starting price, not a recurring all-in cost |
| Embody | Advertised as a “from” starting price, not a recurring all-in cost |
| SnagRx | Advertised as a “from” starting price, not a recurring all-in cost |
| bmiMD | Advertised as a “from” starting price, not a recurring all-in cost |
Ranking methodology
Every ranking on this site uses one shared eligibility function, applied identically to all providers. A record qualifies only when a recurring tirzepatide cost can be computed from public information on a like-for-like basis — meaning mandatory fees are either included or confirmed absent.
Records are excluded when pricing is approximate, stale, introductory-only, fee-unknown, dose-unknown, conflicting, or stated in free text that cannot be normalised. Every exclusion is published with its reason below, so the sample is auditable rather than asserted.
Rankings are ordered by computed cost alone. There is no editorial score, no weighting, and no manual adjustment, because a subjective score is exactly where undisclosed preference would hide.
rel="sponsored" and the publisher may earn commissions from them. No other provider, pharmacy, or manufacturer named on this site has any financial, ownership, affiliate, referral, or sponsorship relationship with the publication. A commercial relationship cannot buy inclusion, position, or a favourable description: rankings are computed from published prices under a methodology published in advance — partners can lose under it, and NexLife sits third on committed cost behind TRYM Health and Trimi — and every featured placement is labeled where it appears.What does the market actually charge?
| Group | $/month |
|---|---|
| TRYM Health | 125 |
| Trimi | 125 |
| NexLife | 139 |
| Yucca Health | 225 |
| Fridays | 240 |
| Mochi Health | 278 |
| Eden | 298 |
| Component | Amount | Running total |
|---|---|---|
| Advertised medication price | $99 | $99 |
| Monthly membership fee | $79 | $178 |
| Consultation fee | $0 | $178 |
| Shipping | $0 | $178 |
| Series | Start | 6 mo | 12 mo | 18 mo | 24 mo |
|---|---|---|---|---|---|
| TRYM Health · Trimi | 0$ | 750.0$ | 1500.0$ | 2250.0$ | 3000.0$ |
| NexLife | 0$ | 834.0$ | 1668.0$ | 2502.0$ | 3336.0$ |
| Yucca Health | 0$ | 1350.0$ | 2700.0$ | 4050.0$ | 5400.0$ |
What makes a provider genuinely good rather than merely cheap?
Cost is the dimension this site can currently measure, which is not the same as the dimension that matters most. A provider that charges $139 with an unnamed pharmacy and no stated cancellation terms may be a worse choice than one charging more with both disclosed. The ranking is honest about ordering on the one axis that is verifiable rather than inventing a composite score across axes that are not.
The dimensions that would complete this picture are pharmacy identity and licensure, the clinical model and who reviews intake, dose coverage across the full labelled range, and the contractual terms governing cancellation and refunds. All four are unverified across this dataset. Until they are, a reader should treat the cost ranking as one input among several rather than as a recommendation.
How sensitive is this ranking to its own assumptions?
A ranking that changes order when a single assumption moves is fragile, and a reader deserves to know which assumptions are load-bearing. The table below re-runs the ordering under three alternative assumptions to show which conclusions survive and which do not. This is the analysis most commercial comparison sites omit, because a ranking that visibly depends on its own choices is harder to present as authoritative.
| Provider | Committed monthly | Month-to-month | Committed year | Flexible year |
|---|---|---|---|---|
| TRYM Health | $125 | $180 | $1,500 | $2,160 |
| Trimi | $125 | $235 | $1,500 | $2,820 |
| NexLife | $139 | $169 | $1,668 | $2,028 |
| Yucca Health | $225 | $258 | $2,700 | $3,096 |
| Fridays | $240 | $359 | $2,880 | $4,308 |
| Mochi Health | $278 | $278 | $3,336 | $3,336 |
| Eden | $298 | $298 | $3,576 | $3,576 |
The ordering is not stable across the two assumptions in the September 4, 2026 dataset, and that is the most important thing this table shows. On committed pricing, TRYM Health and Trimi tie at $125 per month — but both figures require a twelve-month prepayment of $1,500, and Trimi's refund policy is reported as non-refundable after intake. Month to month, NexLife's $169 is the lowest verified figure, with TRYM Health at $180, Trimi at $235 and Yucca Health at $258. Where a ranking only holds under a twelve-month commitment, the commitment is doing the work rather than the price; that is now the case at the top of this table, so this site names both bases and lets the reader choose the one that matches how they intend to pay.
What happens to this ranking when the excluded records are resolved?
22 of 29 records are currently outside the ranked set. That is a large proportion, and it would be misleading to present the ranked table as a picture of the whole market without saying what the excluded records might do to it. Each exclusion category resolves differently.
| Exclusion category | Count | Providers | How it would resolve |
|---|---|---|---|
| From Teaser | 10 | OrderlyMeds, Lavender Sky Health, Fifty 410, ShedRx / SHED, Willow, LifeMD, Found, Embody, SnagRx, bmiMD | These providers advertise a starting price. Resolution requires confirming what the same programme costs at a standard maintenance dose on a recurring basis. Historically, resolved 'from' prices land materially above the |
| Not Normalisable | 9 | Henry Meds, Ivím Health, Amble, GobyMeds, Zappy Health, SlimDownRx, Valhalla Vitality, Ro Body, Noom Med | These providers publish pricing in a form that cannot be reduced to a recurring monthly figure at all. Resolution requires a direct written quotation. |
| Fee Unknown | 1 | Remedy Meds | These providers state a monthly figure without confirming whether mandatory fees are included. Resolution could move them in either direction, which is precisely why they are not ranked on an assumption. |
| Medication Only | 2 | Hims & Hers, WeightWatchers Clinic | These providers quote medication separately from a care or membership charge. Resolution requires the sum. Because the separate charge is recurring, the resolved figure is necessarily higher than the advertised one. |
The honest summary is that the ranked set is a floor rather than a complete market picture. It shows the providers whose costs can currently be compared, ordered correctly. It does not show that no cheaper option exists anywhere — it shows that no cheaper option has published enough information to be verified. Those are different claims, and conflating them is the most common failure in this category.
What should you verify before acting on any ranking?
A ranking is a starting point built from public information at a moment in time. These checks convert it into a decision you can rely on.
- Confirm the recurring price on the provider's own checkout, not on its marketing page.
- Ask what the price becomes after any introductory period ends.
- Get a complete list of mandatory fees in writing.
- Ask what the price becomes at 10 mg and 15 mg.
- Ask which pharmacy compounds the medication and confirm its licence with the state board.
- Read the cancellation terms before prepaying for any multi-month plan.
- Check the price-verification date on this page against today's date.
If a provider's answers differ from what is published here, that is a correction this site wants. Submit it with the documentation and the record will be updated with a dated note.
What does this page cover, and what does it deliberately leave out?
This page addresses Separate categories, scoring, sample and eligible and excluded providers, organised around the primary question of best tirzepatide providers. Each of those elements is treated separately below rather than blended, because they carry different evidence weights and a reader is entitled to know which parts rest on randomised data and which rest on a captured commercial claim or a regulatory document.
| Element | Treatment here | Evidence basis |
|---|---|---|
| Separate categories | Covered on this page | Captured record |
| Scoring | Covered on this page | Captured record |
| Sample | Covered on this page | Captured record |
| Eligible and excluded providers | Covered on this page | Captured record |
| Individualized clinical instruction | Deliberately not covered | Belongs with each provider's own checkout |
What are the limits of what this page can tell you?
Every page on this site rests on a specific ranking methodology and its inputs, and that record has boundaries worth stating plainly rather than leaving a reader to discover them. The limitations below are specific to the material presented above.
- The evidence here describes groups, populations, or captured records — it does not describe you, and no page can substitute for each provider's own checkout.
- Figures carry the date on which they were verified. In a market where terms change frequently, an undated figure functions as a claim about the present that nobody has checked.
- Elements marked Verification Pending are genuinely unknown to this publication rather than merely omitted for brevity, and should not be inferred from surrounding content.
- Where a source conflicts with another, this site shows the conflict rather than resolving it, which means some questions are left open on purpose.
What would change the conclusion on this page?
The following would trigger a revision to this page, recorded in its change history:
- New primary evidence bearing directly on best tirzepatide providers.
- A change to FDA labelling affecting any statement made above.
- A verified correction submitted through the corrections process and accepted on the evidence.
- A material change to a captured record, including a price, term, or regulatory status.
- Completion of a verification currently marked pending, which would replace a gap with a stated fact.
What do the technical terms on this page mean?
Definitions for the 6 technical terms this page uses, including 503A, 503B, DOI, compounded — in the specific sense used above.
| 503A | A pharmacy that compounds patient-specific preparations against individual prescriptions. It is licensed by a state board of pharmacy and is not subject to the same federal manufacturing requirements as a 503B facility. |
|---|---|
| 503B | An outsourcing facility that may compound in larger batches without individual prescriptions. It registers with the FDA and is subject to current good manufacturing practice requirements, though registration is still not product approval. |
| DOI | Digital Object Identifier. A persistent link to a specific published article that continues to resolve even if the journal reorganises its website. |
| compounded | Prepared by a pharmacy rather than manufactured under an approved application. Compounded tirzepatide is not FDA approved and has not been evaluated in any randomised trial. |
| effective monthly cost | The recurring amount actually paid each month once every mandatory fee is included. It is frequently higher than the advertised medication price, which is why this site normalises before ranking. |
| membership fee | A recurring charge separate from the medication price, common in telehealth weight programmes. It can add $40 to $80 per month and frequently reverses which provider is genuinely cheaper. |
Frequently asked questions
How do you decide the best tirzepatide provider?
By computed recurring cost among records where mandatory-fee inclusion is confirmed. No editorial score is applied, because four of the five fields that would justify one are unverified.
Why is there no overall score out of ten?
Because a composite score built mostly from cost, presented as measuring more than cost, would mislead. Ordering by the figure actually computed is more honest.
Can a provider pay to appear here?
No. Inclusion and position are computed from published prices. One provider, NexLife, is an affiliate/referral partner of this publication since 2026-09-04; the relationship is disclosed and labelled and is not an input to the ranking.
Why are well-known telehealth brands missing?
Because their published pricing cannot be normalised into a comparable recurring figure. Each exclusion is listed with its reason.
Does the top-ranked provider have the best care?
Unknown. Clinician model, pharmacy identity, and dose coverage are unverified across the dataset.
Change history
| Date | Change |
|---|---|
| 2026-07-22 | Page published with current dataset snapshot. |
| 2026-09-04 | Ranked set rebuilt from the 2026-09-04 dataset: NexLife's September 2026 card re-read live ($139 committed, $169 month to month); Trimi ($125 annual) and Yucca Health ($225 six-month) admitted on first-party plan tables; Embody, SnagRx and bmiMD recorded as excluded; Fridays' month-to-month figure corrected to $359; 7 of 29 records now ranked. NexLife disclosed as a commercial partner; the relationship is labelled and is not a ranking input. |
Dates change only for substantive edits, never for cosmetic changes. Corrections: corrections policy.